Amino Acid Copolymers That Alleviate Experimental Autoimmune Encephalomyelitis In Vivo Interact with Heparan Sulfates and Glycoprotein 96 in APCs

available in PMC 2014 July 01

Bibliographic Details
Main Authors: Koenig, Paul-Albert, Spooner, Eric, Kawamoto, Norio, Strominger, Jack L., Ploegh, Hidde
Other Authors: Massachusetts Institute of Technology. Department of Biology
Format: Article
Language:en_US
Published: American Association of Immunologists, Inc. 2017
Online Access:http://hdl.handle.net/1721.1/109387
https://orcid.org/0000-0002-1090-6071
_version_ 1826200622895988736
author Koenig, Paul-Albert
Spooner, Eric
Kawamoto, Norio
Strominger, Jack L.
Ploegh, Hidde
author2 Massachusetts Institute of Technology. Department of Biology
author_facet Massachusetts Institute of Technology. Department of Biology
Koenig, Paul-Albert
Spooner, Eric
Kawamoto, Norio
Strominger, Jack L.
Ploegh, Hidde
author_sort Koenig, Paul-Albert
collection MIT
description available in PMC 2014 July 01
first_indexed 2024-09-23T11:39:18Z
format Article
id mit-1721.1/109387
institution Massachusetts Institute of Technology
language en_US
last_indexed 2024-09-23T11:39:18Z
publishDate 2017
publisher American Association of Immunologists, Inc.
record_format dspace
spelling mit-1721.1/1093872022-09-27T21:01:52Z Amino Acid Copolymers That Alleviate Experimental Autoimmune Encephalomyelitis In Vivo Interact with Heparan Sulfates and Glycoprotein 96 in APCs Koenig, Paul-Albert Spooner, Eric Kawamoto, Norio Strominger, Jack L. Ploegh, Hidde Massachusetts Institute of Technology. Department of Biology Ploegh, Hidde available in PMC 2014 July 01 Multiple sclerosis (MS) is an autoimmune disease that affects the CNS. One approved treatment for relapsing forms of MS is YEAK, a random copolymer of the amino acids tyrosine, glutamic acid, alanine, and lysine. YFAK, a second-generation copolymer composed of tyrosine, phenylalanine, alanine, and lysine, is more successful in treating experimental autoimmune encephalomyelitis, a mouse model of MS. Although originally designed and optimized based on the autoantigen myelin basic protein (MBP) and the MBP-derived peptide MBP85-99 presented to the MS-associated class II MHC molecule HLA-DR2, YEAK and YFAK also stimulate cytokine and chemokine production in APCs that lack class II MHC products. How YEAK and YFAK copolymers interact with APCs remains enigmatic. We used biotinylated YFAK to affinity-purify YFAK-interacting proteins from RAW264.7 cells and tested APCs from mice deficient in several of the newly identified interactors for their capacity to secrete CCL22 in response to YEAK and YFAK. We propose that initial contact of YFAK with cells is mediated mainly by electrostatic interactions, and find that interaction of YFAK with host proteins is strongly dependent on ionic strength. Cells deficient in enzymes involved in sulfation of proteins and proteoglycans showed strongly reduced binding of biotinylated YFAK. Lastly, cells stimulated with YFAK in the presence of heparin, structurally similar to heparan sulfates, failed to produce CCL22. We conclude that charge-dependent interactions of copolymers that alleviate MS/experimental autoimmune encephalomyelitis are critical for their effects exerted on APCs and may well be the main initial mediators of these therapeutically active copolymers. National Institutes of Health (U.S.) (NIH grant no. RO1 AI087879) National Institutes of Health (U.S.) (NIH grant AI049524) 2017-05-26T18:46:34Z 2017-05-26T18:46:34Z 2013-07 Article http://purl.org/eprint/type/JournalArticle 0022-1767 1550-6606 http://hdl.handle.net/1721.1/109387 Koenig, Paul-Albert, Eric Spooner, Norio Kawamoto, Jack L. Strominger, and Hidde L. Ploegh. “Amino Acid Copolymers That Alleviate Experimental Autoimmune Encephalomyelitis In Vivo Interact with Heparan Sulfates and Glycoprotein 96 in APCs.” The Journal of Immunology 191, no. 1 (June 5, 2013): 208–216. https://orcid.org/0000-0002-1090-6071 en_US http://dx.doi.org/10.4049/jimmunol.1300345 Journal of Immunology Creative Commons Attribution-Noncommercial-Share Alike http://creativecommons.org/licenses/by-nc-sa/4.0/ application/pdf American Association of Immunologists, Inc. PMC
spellingShingle Koenig, Paul-Albert
Spooner, Eric
Kawamoto, Norio
Strominger, Jack L.
Ploegh, Hidde
Amino Acid Copolymers That Alleviate Experimental Autoimmune Encephalomyelitis In Vivo Interact with Heparan Sulfates and Glycoprotein 96 in APCs
title Amino Acid Copolymers That Alleviate Experimental Autoimmune Encephalomyelitis In Vivo Interact with Heparan Sulfates and Glycoprotein 96 in APCs
title_full Amino Acid Copolymers That Alleviate Experimental Autoimmune Encephalomyelitis In Vivo Interact with Heparan Sulfates and Glycoprotein 96 in APCs
title_fullStr Amino Acid Copolymers That Alleviate Experimental Autoimmune Encephalomyelitis In Vivo Interact with Heparan Sulfates and Glycoprotein 96 in APCs
title_full_unstemmed Amino Acid Copolymers That Alleviate Experimental Autoimmune Encephalomyelitis In Vivo Interact with Heparan Sulfates and Glycoprotein 96 in APCs
title_short Amino Acid Copolymers That Alleviate Experimental Autoimmune Encephalomyelitis In Vivo Interact with Heparan Sulfates and Glycoprotein 96 in APCs
title_sort amino acid copolymers that alleviate experimental autoimmune encephalomyelitis in vivo interact with heparan sulfates and glycoprotein 96 in apcs
url http://hdl.handle.net/1721.1/109387
https://orcid.org/0000-0002-1090-6071
work_keys_str_mv AT koenigpaulalbert aminoacidcopolymersthatalleviateexperimentalautoimmuneencephalomyelitisinvivointeractwithheparansulfatesandglycoprotein96inapcs
AT spoonereric aminoacidcopolymersthatalleviateexperimentalautoimmuneencephalomyelitisinvivointeractwithheparansulfatesandglycoprotein96inapcs
AT kawamotonorio aminoacidcopolymersthatalleviateexperimentalautoimmuneencephalomyelitisinvivointeractwithheparansulfatesandglycoprotein96inapcs
AT stromingerjackl aminoacidcopolymersthatalleviateexperimentalautoimmuneencephalomyelitisinvivointeractwithheparansulfatesandglycoprotein96inapcs
AT ploeghhidde aminoacidcopolymersthatalleviateexperimentalautoimmuneencephalomyelitisinvivointeractwithheparansulfatesandglycoprotein96inapcs